Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 106 articles:
HTML format



Single Articles


    July 2021
  1. LORAS C, Manosa M, Andujar X, Sanchiz V, et al
    Recommendations of the spanish group on crohn's disease and ulcerative colitis (geteccu) on the treatment of strictures in crohn's disease.
    Gastroenterol Hepatol. 2021 Jul 15. pii: S0210-5705(21)00219.
    PubMed     Abstract available


    June 2021
  2. HIJOS-MALLADA G, Sostres C, Gomollon F
    NSAIDs, gastrointestinal toxicity and Inflammatory Bowel Disease.
    Gastroenterol Hepatol. 2021 Jun 19. pii: S0210-5705(21)00201.
    PubMed     Abstract available


  3. FORTUNY BAUZA M, Canete Pizarro F, Calm Salvans A, Calafat Sard M, et al
    Tofacitinib for the treatment of acute severe ulcerative colitis refractory to infliximab.
    Gastroenterol Hepatol. 2021 Jun 9. pii: S0210-5705(21)00188.
    PubMed    


  4. GONZALEZ-MUNOZA C, Briones J, Sang Park H, Garcia-Planella E, et al
    Marginal zone lymphoma under anti-TNF treatment in Crohn disease.
    Gastroenterol Hepatol. 2021 Jun 9. pii: S0210-5705(21)00193.
    PubMed    


    May 2021
  5. PEREZ DE ARCE E, Quera R, Beltran CJ, Madrid AM, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis?
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00143.
    PubMed     Abstract available


  6. SEMPERE L, Bernabeu P, Cameo J, Gutierrez A, et al
    Evolution of the emotional impact in patients with early Inflammatory Bowel Disease during and after Covid-19 lockdown.
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00145.
    PubMed    


    April 2021
  7. GONZALEZ AE, Castillejo ON, Sainz IF, Lopez-Garcia A, et al
    Use of capsule endoscopy in Inflammatory Bowel Disease in clinical practice in Spain. Results from a national survey.
    Gastroenterol Hepatol. 2021 Apr 16. pii: S0210-5705(21)00110.
    PubMed     Abstract available


  8. NUNEZ F P, Quera R, Sepulveda E, Simian D, et al
    Pregnancy in Inflammatory Bowel Disease: Experience of a Chilean cohort.
    Gastroenterol Hepatol. 2021;44:277-285.
    PubMed     Abstract available


    February 2021
  9. SICILIA B, Vicente R, Arias L, Echarri A, et al
    Recommendations of the Spanish Working Group on Crohn's disease and ulcerative colitis (Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa - GETECCU) on dysplasia screening in inflammatory bowel disease patients.
    Gastroenterol Hepatol. 2021 Feb 13. pii: S0210-5705(21)00043.
    PubMed     Abstract available


  10. CRISTINA SF, Angeles RRM, Maria SA, Luis RGJ, et al
    Nutricional Habits In Patients With Inflammatory Bowel Disease: Perception Of Patients And Health Professionals.
    Gastroenterol Hepatol. 2021 Feb 2. pii: S0210-5705(21)00014.
    PubMed    


  11. RODRIGUEZ C, Elosua A, Prieto C, Perez E, et al
    COLECTOMY RATE IN ULCERATIVE COLITIS 15 YEARS AFTER DIAGNOSIS: Results from the 2001-2003 Navarra cohort.
    Gastroenterol Hepatol. 2021 Feb 2. pii: S0210-5705(21)00003.
    PubMed     Abstract available


    January 2021
  12. NAVARRO-CORREAL E, Borruel N, Robles V, de Guise CH, et al
    Impact of the COVID-19 pandemic on the activity of advanced-practice nurses on a reference unit for inflammatory bowel disease.
    Gastroenterol Hepatol. 2021 Jan 27. pii: S0210-5705(21)00005.
    PubMed     Abstract available


    December 2020
  13. MUNOZ F, Ripolles T, Poza Cordon J, de Las Heras Paez de la Cadena B, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Dec 11. pii: S0210-5705(20)30214.
    PubMed     Abstract available


    November 2020
  14. RUBIANO MR, Medina GR, Perez-Riveros ED, Panqueva RDPL, et al
    Proctitis is not always ulcerative colitis.
    Gastroenterol Hepatol. 2020 Nov 25. pii: S0210-5705(20)30441.
    PubMed    


  15. QUERA R, Simian D, Flores L, Ibanez P, et al
    IMPACT OF THE COVID-19 PANDEMIC ON TREATMENT ADHERENCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: EXPERIENCE OF A TERTIARY HOSPITAL IN CHILE.
    Gastroenterol Hepatol. 2020 Nov 21. pii: S0210-5705(20)30438.
    PubMed    


  16. QUERA R, Pizarro G, Simian D, Ibanez P, et al
    Impact of COVID-19 on a cohort of patients with inflammatory bowel disease at a specialised centre in Chile.
    Gastroenterol Hepatol. 2020 Nov 20. pii: S0210-5705(20)30431.
    PubMed    


  17. LADRON ABIA P, Alcala Vicente C, Martinez Delgado S, Bastida Paz G, et al
    Fingolimod-induced remission in a patient with ulcerative colitis and multiple sclerosis.
    Gastroenterol Hepatol. 2020 Nov 13. pii: S0210-5705(20)30364.
    PubMed    


  18. MINGUEZ SABATER A, Martinez Delgado S, Ladron Abia P, Bastida G, et al
    Skin injuries associated with biological therapy in inflammatory bowel disease: beyond psoriasis.
    Gastroenterol Hepatol. 2020 Nov 11. pii: S0210-5705(20)30378.
    PubMed    


  19. LUCAS RAMOS J, Suarez Ferrer C, Poza Cordon J, Sanchez Azofra M, et al
    Optimization of azathioprine dose in combined treatment with anti-TNF-alpha in inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Nov 7. pii: S0210-5705(20)30387.
    PubMed     Abstract available


  20. PEREZ DE ARCE E, Quera R, Nunez P, Simian D, et al
    Management of acute severe ulcerative colitis in chile: Experience of a multidisciplinary team.
    Gastroenterol Hepatol. 2020 Nov 6. pii: S0210-5705(20)30400.
    PubMed    


    October 2020
  21. QUERA R, Simian D, Nunez P, Flores L, et al
    Are patients with inflammatory bowel disease receiving adequate immunisation?
    Gastroenterol Hepatol. 2020 Oct 29. pii: S0210-5705(20)30303.
    PubMed     Abstract available


  22. EZQUERRA A, Resina E, Montes A, Alvarez-Male T, et al
    Pericardial effusion associated with mesalamine treatment in a patient with ulcerative colitis.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30377.
    PubMed    


  23. NUNEZ P, Garcia Mateo S, Quera R, Gomollon F, et al
    Inflammatory bowel disease and the risk of cardiovascular diseases.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30375.
    PubMed     Abstract available


  24. NUNEZ F P, Quera R, Simian D, Flores L, et al
    Infliximab in inflammatory bowel disease. Is premedication necessary?
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30362.
    PubMed     Abstract available


  25. NUNEZ F P, Mahadevan U, Quera R, Bay C, et al
    Treat-to-target approach in the management of inflammatory Bowel disease.
    Gastroenterol Hepatol. 2020 Oct 15. pii: S0210-5705(20)30318.
    PubMed     Abstract available


  26. LOPEZ GONZALEZ J, Hernandez Martinez A, Lazaro Saez M, Vega Saenz JL, et al
    Experience with tofacitinib in patients with refractary ulcerative colitis.
    Gastroenterol Hepatol. 2020 Oct 10. pii: S0210-5705(20)30309.
    PubMed    


  27. GARCIA-ALANIS M, Quiroz-Casian L, Castaneda-Gonzalez H, Arguelles-Castro P, et al
    Prevalence of mental disorder and impact on quality of life in inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Oct 8. pii: S0210-5705(20)30304.
    PubMed     Abstract available


  28. DEL HOYO J, Aguas M
    Implementing telemedicine in inflammatory bowel disease: Is COVID-19 the definitive trigger?
    Gastroenterol Hepatol. 2020;43:415-417.
    PubMed    


    August 2020
  29. MORENO MORALEDA I, Lazaro Saez M, Dieguez Castillo C, Hernandez Martinez A, et al
    Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link?
    Gastroenterol Hepatol. 2020 Aug 31. pii: S0210-5705(20)30245.
    PubMed    


  30. MORENO MORALEDA I, Lazaro Saez M, Dieguez Castillo C, Hernandez Martinez A, et al
    Immunotherapy-induced colitis: Could it be ulcerative colitis?
    Gastroenterol Hepatol. 2020 Aug 29. pii: S0210-5705(20)30243.
    PubMed    


  31. LOPEZ-SANROMAN A, Esplugues JV, Domenech E
    Pharmacology and safety of tofacitinib in ulcerative colitis.
    Gastroenterol Hepatol. 2020 Aug 20. pii: S0210-5705(20)30236.
    PubMed     Abstract available


  32. RIESTRA S, Taxonera C, Zabana Y, Carpio D, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Aug 19. pii: S0210-5705(20)30217.
    PubMed     Abstract available


  33. MARIN-JIMENEZ I, Gomollon F
    Year 1983: Smoking decreases the risk of ulcerative colitis.
    Gastroenterol Hepatol. 2020;43:373-374.
    PubMed    


  34. MARIN-JIMENEZ I, Gomollon F
    Year 2005: Clinical, serological and molecular classification of inflammatory bowel disease.
    Gastroenterol Hepatol. 2020;43:383-384.
    PubMed    


  35. SICILIA B, Garcia-Lopez S, Gonzalez-Lama Y, Zabana Y, et al
    GETECCU 2020 guidelines for the treatment of ulcerative colitis. Developed using the GRADE approach.
    Gastroenterol Hepatol. 2020;43 Suppl 1:1-57.
    PubMed     Abstract available


    July 2020
  36. ZHOU G, Xiong F, Yang X, Wang P, et al
    A case report of drug-induced ischemic colitis accompanied by ulcerative colitis.
    Gastroenterol Hepatol. 2020 Jul 24. pii: S0210-5705(20)30170.
    PubMed    


  37. ELORZA A, Rodriguez-Lago I, Martinez P, Hidalgo A, et al
    Gastrointestinal infection with Aeromonas: incidence and relationship to inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Jul 21. pii: S0210-5705(20)30238.
    PubMed     Abstract available


  38. ZABANA Y, Panes J, Nos P, Gomollon F, et al
    The ENEIDA registry (Nationwide study on genetic and environmental determinants of inflammatory bowel disease) by GETECCU: Design, monitoring and functions.
    Gastroenterol Hepatol. 2020 Jul 13. pii: S0210-5705(20)30165.
    PubMed     Abstract available


  39. MERINO GALLEGO E, Gomez Torres K, Martinez Amate E
    Debut Of Inflammatory Bowel Disease Associated To Ixekizumab In Patient With Moderate, Difficult -To-Manage Psoriasis.
    Gastroenterol Hepatol. 2020 Jul 13. pii: S0210-5705(20)30229.
    PubMed    


    June 2020
  40. BARREIRO-DE ACOSTA M, Marin-Jimenez I, Rodriguez-Lago I, Guarner F, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.
    Gastroenterol Hepatol. 2020 Jun 26. pii: S0210-5705(20)30160.
    PubMed     Abstract available


  41. MARIN-JIMENEZ I, Gomollon F
    History of inflammatory bowel disease on eleven infographics.
    Gastroenterol Hepatol. 2020 Jun 24. pii: S0210-5705(20)30166.
    PubMed    


  42. FERNANDEZ-DE LA VARGA M, Del Pozo-Del Valle P, Bejar-Serrano S, Garrido-Marin A, et al
    Secukinumab-induced ulcerative colitis: opening Pandora's box of immunity.
    Gastroenterol Hepatol. 2020 Jun 17. pii: S0210-5705(20)30156.
    PubMed    


    May 2020
  43. MARIN-JIMENEZ I, Zabana Y, Rodriguez-Lago I, Marin L, et al
    [COVID-19 and inflammatory bowel disease: questions arising from patient care and follow-up during the initial phase of the pandemic (February-April 2020)].
    Gastroenterol Hepatol. 2020 May 15. pii: S0210-5705(20)30138.
    PubMed     Abstract available


    April 2020
  44. RAMOS LOPEZ L, Hernandez Camba A, Rodriguez-Lago I, Carrillo Palau M, et al
    Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2020 Apr 26. pii: S0210-5705(20)30111.
    PubMed     Abstract available


  45. GONZALEZ-LAMA Y, Sanz J, Bastida G, Campos J, et al
    Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis.
    Gastroenterol Hepatol. 2020 Apr 1. pii: S0210-5705(20)30072.
    PubMed     Abstract available


  46. POUS S, Frasson M, Jimenez R, Pamies J, et al
    Relevance of dynamic studies with magnetic resonance enterography in Crohn's disease.
    Gastroenterol Hepatol. 2020;43:179-187.
    PubMed     Abstract available


    March 2020
  47. CASAS DEZA D, Garcia Lopez S, Lafuente Blasco M, Vicente Lidon R, et al
    Efficacy and safety of ustekinumab in real clinical practice. Retrospective multicentre study. ARAINF cohort.
    Gastroenterol Hepatol. 2020;43:126-132.
    PubMed     Abstract available


    January 2020
  48. CASANOVA MJ, Chaparro M, Gisbert JP
    Errors in the care of inflammatory bowel disease patients: "Errata" Study.
    Gastroenterol Hepatol. 2020 Jan 18. pii: S0210-5705(19)30260.
    PubMed     Abstract available


  49. ALONSO-ABREU I, Alarcon-Fernandez O, Carrillo-Palau M, Ramos-Lopez L, et al
    Survey of adherence to treatment in inflammatory bowel disease. ENADEII study.
    Gastroenterol Hepatol. 2020 Jan 13. pii: S0210-5705(19)30263.
    PubMed     Abstract available


  50. GELY C, Marin L, Gordillo J, Manosa M, et al
    Impact of pain associated with the subcutaneous administration of adalimumab.
    Gastroenterol Hepatol. 2020;43:9-13.
    PubMed     Abstract available


    December 2019
  51. BOSCA MM, Alos R, Maroto N, Gisbert JP, et al
    Recommendations of the Crohn's Disease and Ulcerative Colitis Spanish Working Group (GETECCU) for the treatment of perianal fistulas of Crohn's disease.
    Gastroenterol Hepatol. 2019 Dec 20. pii: S0210-5705(19)30259.
    PubMed     Abstract available


  52. GINARD D, Marin-Jimenez I, Barreiro-de Acosta M, Ricart E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on topical therapy in ulcerative colitis.
    Gastroenterol Hepatol. 2019 Dec 12. pii: S0210-5705(19)30256.
    PubMed     Abstract available


    November 2019
  53. SHENTOVA R, Baycheva M, Hadjiiski P, Kofinova D, et al
    Role of faecal calprotectin as a predictor of endoscopic activity in paediatric patients with ulcerative colitis.
    Gastroenterol Hepatol. 2019 Nov 13. pii: S0210-5705(19)30220.
    PubMed     Abstract available


    October 2019
  54. BERMEJO F, Algaba A, Bonillo D, Jimenez L, et al
    Limitations of the determination of faecal calprotectin in patients with ulcerative colitis and inflammatory polyps.
    Gastroenterol Hepatol. 2019 Oct 21. pii: S0210-5705(19)30198.
    PubMed     Abstract available


  55. MURZI M, Gordillo J, Oblitas E, Soriano G, et al
    Spontaneous hepatic portal venous gas in a patient with ulcerative colitis. A case report and a review.
    Gastroenterol Hepatol. 2019 Oct 19. pii: S0210-5705(19)30199.
    PubMed    


  56. HINOJOSA DEL VAL J, Barreiro-de Acosta M
    Questions and answers about the management of Crohn's disease and ulcerative colitis with vedolizumab.
    Gastroenterol Hepatol. 2019 Oct 18. pii: S0210-5705(19)30202.
    PubMed     Abstract available


  57. BARREIRO-DE ACOSTA M, Gutierrez A, Rodriguez-Lago I, Espin E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.
    Gastroenterol Hepatol. 2019 Oct 9. pii: S0210-5705(19)30195.
    PubMed     Abstract available


  58. CEBRIAN GARCIA A, Ruiz-Clavijo D, Irisarri Garde R, Gonzalez de la Higuera Carnicer B, et al
    Bronchiolitis obliterans organizing pneumonia in Crohn's disease.
    Gastroenterol Hepatol. 2019;42:496-497.
    PubMed    


    September 2019
  59. VELAYOS JIMENEZ B, Cuello Garcia R, Del Olmo Martinez L, Macho Conesa A, et al
    Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab.
    Gastroenterol Hepatol. 2019 Sep 2. pii: S0210-5705(19)30168.
    PubMed    


    August 2019
  60. OLMEDO-MARTIN RV, Gonzalez-Molero I, Olveira G, Amo-Trillo V, et al
    Sunlight exposure in inflammatory bowel disease outpatients: Predictive factors and correlation with serum vitaminD.
    Gastroenterol Hepatol. 2019 Aug 28. pii: S0210-5705(19)30167.
    PubMed     Abstract available


  61. RODRIGUEZ-LAGO I, Merino O, Lopez de Goicoechea MJ, Aranzamendi M, et al
    Immunosuppression for inflammatory bowel disease does not influence Epstein-Barr viral load in the short-term.
    Gastroenterol Hepatol. 2019 Aug 8. pii: S0210-5705(19)30159.
    PubMed     Abstract available


  62. PENA-VELEZ R, Almanza-Miranda E, Zaragoza-Arevalo GR
    Crohn's disease in a girl with VACTERL association: Can mitochondrial dysfunction coexist?
    Gastroenterol Hepatol. 2019;42:435-436.
    PubMed    


    June 2019
  63. FERRER BRADLEY I, Maroto Arce N, Mora Escrig M, Hinojosa Del Val J, et al
    Pulmonary aspergillosis in a Crohn's disease patient receiving adalimumab and steroid therapy.
    Gastroenterol Hepatol. 2019;42:387-388.
    PubMed    


    May 2019
  64. CASAS DEZA D, Llorente Barrio M, Monzon Baez RM, Lamuela Calvo LJ, et al
    It is not always Crohn's disease: Amebiasis as a differential diagnosis of inflammatory bowel disease.
    Gastroenterol Hepatol. 2019 May 20. pii: S0210-5705(19)30100.
    PubMed    


  65. PANES J, Gisbert JP
    Efficacy of tofacitinib treatment in ulcerative colitis.
    Gastroenterol Hepatol. 2019 May 14. pii: S0210-5705(19)30094.
    PubMed     Abstract available


    April 2019
  66. SEDANO MUNOZ R, Quera Pino R, Ibanez Lazo P, Figueroa Corona C, et al
    Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
    Gastroenterol Hepatol. 2019 Apr 3. pii: S0210-5705(19)30056.
    PubMed     Abstract available


  67. NUNEZ F P, Quera P R, Gomollon F
    Primary sclerosing cholangitis and inflammatory bowel disease: Intestine-liver interrelation.
    Gastroenterol Hepatol. 2019 Apr 1. pii: S0210-5705(19)30055.
    PubMed     Abstract available


  68. FRASER CG
    Faecal immunochemical tests for haemoglobin (FIT) in the assessment of patients with lower abdominal symptoms: current controversies.
    Gastroenterol Hepatol. 2019;42:263-270.
    PubMed     Abstract available


    March 2019
  69. NAVARRO B, Blazquez T, Herreras J, Iborra M, et al
    Acute myocardial infarction in a patient with a recent diagnosis of Crohn's disease.
    Gastroenterol Hepatol. 2019;42:183-184.
    PubMed    


  70. GONZALEZ-OLIVARES C, Palomera-Rico A, Romera-Pintor Blanca N, Sanchez-Aldehuelo R, et al
    Pneumatosis intestinalis in Crohn's disease.
    Gastroenterol Hepatol. 2019;42:181-183.
    PubMed    


    February 2019
  71. RIOS LEON R, Jaureguizar Oriol A, Lopez-Sanroman A, Jimenez Castro D, et al
    Acute severe pulmonary toxicity due to biosimilar infliximab in a Crohn's disease patient.
    Gastroenterol Hepatol. 2019;42:104-105.
    PubMed    


    January 2019
  72. HERNANZ N, Sierra M, Volpato N, Nunez-Gomez L, et al
    Autologous haematopoietic stem cell transplantation in refractory Crohn's disease: Experience in our centre.
    Gastroenterol Hepatol. 2019;42:16-22.
    PubMed     Abstract available


  73. SILVA M, Rios E, Peixoto A, Macedo G, et al
    Intestinal pseudopolyps in a patient with Crohn's disease and renal transplant - An unexpected diagnosis.
    Gastroenterol Hepatol. 2019;42:32-33.
    PubMed    


  74. GARCIA-MORALES N, Garcia-Campos M, Cordon G, Iborra M, et al
    Intestinal tuberculosis simulating Crohn's disease: Differential diagnosis.
    Gastroenterol Hepatol. 2019;42:29-32.
    PubMed    


  75. BRUNET E, Martinez de Sola M, Garcia-Iglesias P, Calvet X, et al
    Immune thrombocytopenic purpura associated with Crohn's disease with complete response to infliximab.
    Gastroenterol Hepatol. 2019;42:37-38.
    PubMed    


    December 2018
  76. SEDANO MUNOZ R, Quera Pino R, Lubascher Correa J, Pizarro Jofre G, et al
    Evaluation of de-escalation of anti-TNF-alpha therapy in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Dec 27. pii: S0210-5705(18)30317.
    PubMed     Abstract available


    November 2018
  77. LLORENTE BARRIO M, Garcia Lopez S, Gilaberte Calzada Y, Monzon Baez RM, et al
    Bilateral pyoderma gangrenosum associated with ulcerative colitis and restorative proctocolectomy.
    Gastroenterol Hepatol. 2018 Nov 20. pii: S0210-5705(18)30285.
    PubMed    


    October 2018
  78. RODRIGUEZ-LAGO I, Ferreiro-Iglesias R, Nos P, Gisbert JP, et al
    Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey.
    Gastroenterol Hepatol. 2018 Oct 4. pii: S0210-5705(18)30251.
    PubMed     Abstract available


  79. GUARDIOLA J, Lobaton T, Cerrillo E, Ferreiro-Iglesias R, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018;41:514-529.
    PubMed     Abstract available


    August 2018
  80. SANCHEZ RODRIGUEZ E, Rios Leon R, Mesonero Gismero F, Albillos A, et al
    Clinical experience of optimising thiopurine use through metabolite measurement in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Aug 11. pii: S0210-5705(18)30205.
    PubMed     Abstract available


  81. LOPEZ-SANROMAN A, Clofent J, Garcia-Planella E, Menchen L, et al
    Reviewing the therapeutic role of budesonide in Crohn's disease.
    Gastroenterol Hepatol. 2018;41:458-471.
    PubMed     Abstract available


    July 2018
  82. NUNEZ-GOMEZ L, Mesonero-Gismero F, Albillos-Martinez A, Lopez-Sanroman A, et al
    Anti-tumor necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease.
    Gastroenterol Hepatol. 2018 Jul 24. pii: S0210-5705(18)30195.
    PubMed     Abstract available


  83. IBORRA M, Beltran B, Maroto N, Navarro-Cortes P, et al
    Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
    Gastroenterol Hepatol. 2018 Jul 18. pii: S0210-5705(18)30186.
    PubMed     Abstract available


  84. MIRANDA-BAUTISTA J, Menchen L
    Adalimumab-induced autoimmune hepatitis in a patient with Crohn's disease.
    Gastroenterol Hepatol. 2018 Jul 17. pii: S0210-5705(18)30191.
    PubMed    


    June 2018
  85. YAMAMOTO-FURUSHO JK, Sarmiento-Aguilar A, Garcia-Alanis M, Gomez-Garcia LE, et al
    Hospital Anxiety and Depression Scale (HADS): Validation in Mexican Patients with Inflammatory Bowel Disease.
    Gastroenterol Hepatol. 2018 Jun 21. pii: S0210-5705(18)30138.
    PubMed     Abstract available


    May 2018
  86. GISBERT JP, Chaparro M
    Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.
    Gastroenterol Hepatol. 2018 May 9. pii: S0210-5705(18)30108.
    PubMed     Abstract available


  87. RODRIGUEZ-LAGO I, Benitez JM, Garcia-Sanchez V, Gutierrez A, et al
    Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Gastroenterol Hepatol. 2018 May 5. pii: S0210-5705(18)30110.
    PubMed     Abstract available


    April 2018
  88. SUAREZ FERRER C, Poza Cordon J, Cerpa Arencibia A, Sanchez Azofra M, et al
    Perspectiva actual hospitalization in inflammatory bowel disease: Current perspective.
    Gastroenterol Hepatol. 2018 Apr 7. pii: S0210-5705(18)30034.
    PubMed    


    March 2018
  89. FRAILE LOPEZ M, de Francisco R, Perez-Martinez I, Garcia Garcia B, et al
    Pyoderma gangrenosum and primary cutaneous cryptococcosis in an ulcerative colitis patient.
    Gastroenterol Hepatol. 2018 Mar 5. pii: S0210-5705(18)30050.
    PubMed    


    February 2018
  90. GOBBO M, Carmona L, Panadero A, Canas M, et al
    The psychosocial impact of inflammatory bowel disease and its management. From the patients' perspective.
    Gastroenterol Hepatol. 2018 Feb 5. pii: S0210-5705(18)30006.
    PubMed    


  91. MERINO RODRIGUEZ E, Carrera Alonso E, Torralba Gonzalez de Suso M, Sanchez da Silva M, et al
    Ionizing diagnostic radiation exposure in patients with Crohn's disease: A retrospective study in a medium hospital and its predictive factors.
    Gastroenterol Hepatol. 2018;41:97-102.
    PubMed     Abstract available


    January 2018
  92. BERMEJO F, Aguas M, Chaparro M, Domenech E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of tiopurines in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Jan 18. pii: S0210-5705(17)30248.
    PubMed     Abstract available


    December 2017
  93. BARREIRO-DE ACOSTA M, Marin-Jimenez I, Panadero A, Guardiola J, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease pa
    Gastroenterol Hepatol. 2017 Dec 20. pii: S0210-5705(17)30244.
    PubMed     Abstract available


  94. DE LA PISCINA PR, Delgado E, Duca I, Estrada S, et al
    Acute infection due to Mycobacterium marinum in a patient with ulcerative colitis and metabolic syndrome on infliximab therapy.
    Gastroenterol Hepatol. 2017 Dec 16. pii: S0210-5705(17)30241.
    PubMed    


    September 2017
  95. GONZALEZ ALAYON C, Pedrajas Crespo C, Marin Pedrosa S, Benitez JM, et al
    Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
    Gastroenterol Hepatol. 2017 Sep 9. pii: S0210-5705(17)30189.
    PubMed     Abstract available


  96. SANZ SANZ J, Juanola Roura X, Seoane-Mato D, Montoro M, et al
    Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology.
    Gastroenterol Hepatol. 2017 Sep 4. pii: S0210-5705(17)30184.
    PubMed     Abstract available


    August 2017
  97. GUERRERO PUENTE L, Iglesias Flores E, Benitez JM, Medina Medina R, et al
    Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
    Gastroenterol Hepatol. 2017 Aug 30. pii: S0210-5705(17)30182.
    PubMed     Abstract available


  98. AGUAS M, Del Hoyo J, Faubel R, Valdivieso B, et al
    Telemedicine in the treatment of patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Aug 7. pii: S0210-5705(17)30166.
    PubMed     Abstract available


    July 2017
  99. TORRES P, Lobaton T, Canete F, Clos A, et al
    Cytomegalovirus primoinfection in inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Jul 19. pii: S0210-5705(17)30161.
    PubMed    


    June 2017
  100. AGUD FERNANDEZ M, Lopez Lopez F, Diaz Pedroche C, Gomez-Martin C, et al
    Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterol Hepatol. 2017 Jun 24. pii: S0210-5705(17)30136.
    PubMed    


  101. DOMENECH E, Lopez-Sanroman A, Nos P, Vera M, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.
    Gastroenterol Hepatol. 2017 Jun 9. pii: S0210-5705(17)30126.
    PubMed     Abstract available


    February 2017
  102. SEBASTIAN DOMINGO JJ
    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    PubMed     Abstract available


    December 2016
  103. MONTESERIN L, Jimenez M, Molina G, Reyes N, et al
    Colonic pseudopolyposis in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Dec 21. pii: S0210-5705(16)30161.
    PubMed    


    September 2016
  104. GARCIA-LOPEZ S
    Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.
    Gastroenterol Hepatol. 2016;39 Suppl 1:29-35.
    PubMed     Abstract available


  105. CHAPARRO M
    Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
    Gastroenterol Hepatol. 2016;39 Suppl 1:20-28.
    PubMed     Abstract available


  106. GOMOLLON F
    Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016;39 Suppl 1:14-19.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: